Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer

  Free Subscription


05.09.2022

1 Acad Radiol
3 Afr Health Sci
1 Am J Obstet Gynecol
1 Anal Bioanal Chem
1 Anal Chim Acta
1 Anticancer Res
1 Appl Bionics Biomech
3 Arch Gynecol Obstet
6 Asian Pac J Cancer Prev
1 BMC Cancer
1 BMC Womens Health
1 BMJ Open
1 Cancer Lett
1 Cancer Manag Res
1 Carcinogenesis
1 Clin Cancer Res
1 Comput Biol Med
1 Curr Mol Med
1 Epidemiol Serv Saude
1 Front Biosci (Landmark Ed)
3 Front Oncol
1 Front Pharmacol
1 Front Public Health
2 Gynecol Obstet Invest
1 Indian J Community Med
1 Int J Cancer
1 Int J Gynaecol Obstet
1 Int J Surg
1 J Am Soc Cytopathol
1 J Appl Stat
1 J Cancer Res Clin Oncol
1 J Exp Clin Cancer Res
1 J Gynecol Obstet Hum Reprod
1 J Gynecol Oncol
2 J Obstet Gynaecol Res
1 J Oncol
1 J Transl Med
1 Oncol Lett
1 Pan Afr Med J
3 PLoS One
1 Proteomics Clin Appl
1 Radiat Oncol
1 Rejuvenation Res
1 Reprod Health
1 Sci Rep
1 Sex Health
1 Virol J
1 Zhonghua Fu Chan Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acad Radiol

  1. ZHANG Y, Liu L, Zhang K, Su R, et al
    Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
    Acad Radiol. 2022 Aug 29. pii: S1076-6332(22)00423.
    PubMed         Abstract available


    Afr Health Sci

  2. LEDAGA NA, Woromogo SH, Yagata-Moussa FE, Mavoungou AS, et al
    Cervical precancerous lesions at the Tchibanga Regional Hospital and the University Hospital in Gabon in 2018: smartphone as a screening tool for diagnosis.
    Afr Health Sci. 2022;22:92-97.
    PubMed         Abstract available

  3. LUKMAN Y, Bala DA, Malik KI, Saidu A, et al
    Identification of HPV16's E6 gene in suspected cases of cervical lesions and docking Study of its L1 protein with active components of Echinacea purpurae.
    Afr Health Sci. 2022;22:98-105.
    PubMed         Abstract available

  4. KINOTIA NJ, Muturib M, Kamauc L, Lwembed R, et al
    Human Papillomavirus types prevalence and their association with cervical dysplasia among HIV and non-HIV infected women attending reproductive health clinics in Eastern Kenya.
    Afr Health Sci. 2022;22:106-114.
    PubMed         Abstract available


    Am J Obstet Gynecol

  5. HUEPENBECKER SP, Fu S, Sun CC, Zhao H, et al
    Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis.
    Am J Obstet Gynecol. 2022 Apr 29. pii: S0002-9378(22)00326.
    PubMed         Abstract available


    Anal Bioanal Chem

  6. GU Y, Li Z, Ge S, Mao Y, et al
    A microfluidic chip using Au@SiO2 array-based highly SERS-active substrates for ultrasensitive detection of dual cervical cancer-related biomarkers.
    Anal Bioanal Chem. 2022 Sep 2. pii: 10.1007/s00216-022-04296.
    PubMed         Abstract available


    Anal Chim Acta

  7. BARHOUM A, J Forster R
    Label-free electrochemical immunosensor for picomolar detection of the cervical cancer biomarker MCM5.
    Anal Chim Acta. 2022;1225:340226.
    PubMed         Abstract available


    Anticancer Res

  8. LEE Y, Bae H, Kim HS
    Endocervical Adenocarcinoma: Comprehensive Histological Review and Re-classification of 123 Consecutive Cases According to the Updated World Health Organization Classification of Female Genital Tumors.
    Anticancer Res. 2022;42:4627-4639.
    PubMed         Abstract available


    Appl Bionics Biomech

  9. SUN G, Zhang Q, Liu Y, Xie P, et al
    Role of Phosphatidylinositol 3-Kinase and Its Catalytic Unit PIK3CA in Cervical Cancer: A Mini-Review.
    Appl Bionics Biomech. 2022;2022:6904769.
    PubMed         Abstract available


    Arch Gynecol Obstet

  10. MIRANDEZ CC, Yoneda JY, Gertrudes LN, Carvalho CF, et al
    The value of the endocervical margin status in LEEP: analysis of 610 cases.
    Arch Gynecol Obstet. 2022;306:851-856.
    PubMed         Abstract available

  11. KASRAEI S, Ghahghaei-Nezamabadi A, Seifollahi A, Aghajani F, et al
    Comparison of cytopathologic findings in patients with negative Pap test and positive high-risk HPV infection among three groups.
    Arch Gynecol Obstet. 2022;306:857-863.
    PubMed         Abstract available

  12. JIA P, Cui R, Zhang Y
    Primary ewing sarcoma in the uterine cervix with multiple bone metastases.
    Arch Gynecol Obstet. 2022;306:911-912.
    PubMed         Abstract available


    Asian Pac J Cancer Prev

  13. SHI H, Ma Y, Shao Y, Zhang Y, et al
    Cytology, High-Risk Human Papillomavirus Testing and Serum CA19-9 in a Large Cohort of Patients with Invasive Cervical Adenocarcinomas: Correlation with a New Pathogenetic Classification.
    Asian Pac J Cancer Prev. 2022;23:2599-2605.
    PubMed         Abstract available

  14. MAHENDRA INB, Prayudi PKA, Dwija IBNP, Suwiyoga K, et al
    HPV16-E6/E7 Oncogene Mutation and p53 Expression among Indonesian Women with Cervical Cancer.
    Asian Pac J Cancer Prev. 2022;23:2705-2711.
    PubMed         Abstract available

  15. SOMANNA SN, Sastry NB, Chaluvarayaswamy R, Malila N, et al
    Quality of life and Its Determinants among Cervical Cancer Patients in South India.
    Asian Pac J Cancer Prev. 2022;23:2727-2733.
    PubMed         Abstract available

  16. SRIVASTAVA S, Kurian K, Garg PR, Rehman A, et al
    Prevalence and Predictors of Cervical Cancer Screening among Reproductive Age Group Women: Evidence from Cross-Sectional Study in Rohtak and Delhi.
    Asian Pac J Cancer Prev. 2022;23:2771-2777.
    PubMed         Abstract available

  17. MALHOTRA RK, Manoharan N, Deo SS
    The Trend and Prediction of Cervical Cancer Incidence in Delhi, India: An Age-Period-Cohort Analysis.
    Asian Pac J Cancer Prev. 2022;23:2787-2795.
    PubMed         Abstract available

  18. DATKHILE KD, Durgawale PP, Gudur RA, Gudur AK, et al
    CYP2D6 and CYP2E1 Gene Polymorphisms and their Association with Cervical Cancer Susceptibility: A Hospital Based Case-Control Study from South-Western Maharashtra.
    Asian Pac J Cancer Prev. 2022;23:2591-2597.
    PubMed         Abstract available


    BMC Cancer

  19. DORJI N, Tshering S, Choden S, Chhetri M, et al
    Evaluation of the diagnostic performance of colposcopy in the diagnosis of histologic cervical intraepithelial neoplasia 2+ (CIN2+).
    BMC Cancer. 2022;22:930.
    PubMed         Abstract available


    BMC Womens Health

  20. ZENG Y, Jiang T, Zheng Y, Yang J, et al
    Risk factors predicting residual lesion in subsequent hysterectomy following cold knife conization (CKC) for high-grade squamous intraepithelial lesion (HSIL).
    BMC Womens Health. 2022;22:358.
    PubMed         Abstract available


    BMJ Open

  21. MURENZI G, Shumbusho F, Hansen N, Munyaneza A, et al
    Long-term human papillomavirus vaccination effectiveness and immunity in Rwandan women living with and without HIV: a study protocol.
    BMJ Open. 2022;12:e061650.
    PubMed         Abstract available


    Cancer Lett

  22. XIANG T, Du L, Pham P, Zhu B, et al
    Corrigendum to "Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway" [Cancer Letters 364 (2015) 79-88].
    Cancer Lett. 2022 Aug 25:215895. doi: 10.1016/j.canlet.2022.215895.
    PubMed        


    Cancer Manag Res

  23. DIRAR A, Mekonnen W, Berhanu Z
    The Experiences of Cervical Cancer Patients During Follow-Up Care in Ethiopia: A Qualitative Study.
    Cancer Manag Res. 2022;14:2507-2518.
    PubMed         Abstract available


    Carcinogenesis

  24. LI D, Guan M, Cao X, Qiang Zha Z, et al
    GFPT1 promotes the proliferation of cervical cancer via regulating the ubiquitination and degradation of PTEN.
    Carcinogenesis. 2022 Aug 30. pii: 6679199. doi: 10.1093.
    PubMed         Abstract available


    Clin Cancer Res

  25. HAN K, Fyles A, Shek T, Croke J, et al
    A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer.
    Clin Cancer Res. 2022 Aug 29. pii: 708819. doi: 10.1158/1078-0432.CCR-22-1665.
    PubMed         Abstract available


    Comput Biol Med

  26. NGUYEN TB, Do DN, Nguyen-Thi ML, Hoang-The H, et al
    Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics.
    Comput Biol Med. 2022;149:105996.
    PubMed         Abstract available


    Curr Mol Med

  27. LI W, Yang C, Shi Z, Long Q, et al
    Caffeic Acid Phenethyl Ester Inhibits Ubiquitination and Degradation of p53 and Blocks Cervical Cancer Cell Growth.
    Curr Mol Med. 2022 Aug 29. pii: CMM-EPUB-125993.
    PubMed         Abstract available


    Epidemiol Serv Saude

  28. SOUZA GRM, Cardoso AM, Picoli RP, Mattos IE, et al
    Profile of cervical cancer screening in Campo Grande, Mato Grosso do Sul, Brazil: an evaluative study, 2006-2018.
    Epidemiol Serv Saude. 2022;31:e20211179.
    PubMed         Abstract available


    Front Biosci (Landmark Ed)

  29. XU Z, Zhao X, Shu H, Luo W, et al
    Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of Cervical Cancer in a Subcutaneous Xenograft Mouse Model.
    Front Biosci (Landmark Ed). 2022;27:238.
    PubMed         Abstract available


    Front Oncol

  30. GUANI B, Gaillard T, Teo-Fortin LA, Balaya V, et al
    Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application.
    Front Oncol. 2022;12:935628.
    PubMed         Abstract available

  31. QI L, Li N, Lin A, Wang X, et al
    Efficacy and safety of pembrolizumab on cervical cancer: A systematic review and single-arm meta-analysis.
    Front Oncol. 2022;12:910486.
    PubMed         Abstract available

  32. LIN H, Wang D, Li H, Wu C, et al
    Survival, treatment pattern, and treatment outcome in patients with cervical cancer metastatic to distant lymph nodes.
    Front Oncol. 2022;12:952480.
    PubMed         Abstract available


    Front Pharmacol

  33. HUANG D, He Q, Zhai L, Shen J, et al
    Efficacy and Safety of Apatinib for the Treatment of Advanced or Recurrent Cervical Cancer: A Single-Arm Meta-Analysis Among Chinese Patients.
    Front Pharmacol. 2022;13:843905.
    PubMed         Abstract available


    Front Public Health

  34. SUN Y, Ma Y, Cao M, Hu Z, et al
    Breast and cervical cancer screening adherence in Jiangsu, China: An ecological perspective.
    Front Public Health. 2022;10:967495.
    PubMed         Abstract available


    Gynecol Obstet Invest

  35. ZHAO N, Hu L, Chen H
    Circ_0002762 accelerates glycolysis metabolism to promote cervical cancer progression via the miR-526b-5p/HK2 axis.
    Gynecol Obstet Invest. 2022 Aug 30. pii: 000526700. doi: 10.1159/000526700.
    PubMed         Abstract available

  36. WANG R, Zhang Y, Zhu Y, Li Q, et al
    Clinical characteristics and prognosis of cervical cancer patients with human immunodeficiency virus infection: A retrospective study.
    Gynecol Obstet Invest. 2022 Aug 29. pii: 000526270. doi: 10.1159/000526270.
    PubMed         Abstract available


    Indian J Community Med

  37. SESHADRI L, Kaliyaperumal K
    Screening for Cervical Cancer Using Visual Inspection after Acetic Acid in a Rural and Semiurban Population in South India.
    Indian J Community Med. 2022;47:304-305.
    PubMed        


    Int J Cancer

  38. NORMAN I, Yilmaz E, Hjerpe A, Hortlund M, et al
    Atypical glandular cells and development of cervical cancer: Population-based cohort study.
    Int J Cancer. 2022 Aug 13. doi: 10.1002/ijc.34242.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  39. MAILLIE L, Yussuph A, Chirangi B, Schroeder K, et al
    Outcomes From Eight Years of Cervical Cancer Screening at a Rural Screen-and-Treat Site in Northern Tanzania.
    Int J Gynaecol Obstet. 2022 Sep 2. doi: 10.1002/ijgo.14429.
    PubMed         Abstract available


    Int J Surg

  40. SANNA E, Madeddu C, Lavra F, Oppi S, et al
    Laparoscopic management of isolated nodal recurrence in gynecological malignancies is safe and feasible even for large metastatic nodes up to 8 cm: A prospective case series.
    Int J Surg. 2022;104:106744.
    PubMed         Abstract available


    J Am Soc Cytopathol

  41. COMPTON ML, Taylor SS, Weeks AG, Weiss VL, et al
    Cytology and LGBT+ health: establishing inclusive cancer screening programs.
    J Am Soc Cytopathol. 2022;11:241-252.
    PubMed         Abstract available


    J Appl Stat

  42. DE SOUZA HCC, Louzada F, Ramos PL, de Oliveira Junior MR, et al
    A Bayesian approach for the zero-inflated cure model: an application in a Brazilian invasive cervical cancer database.
    J Appl Stat. 2021;49:3178-3194.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  43. XU HH, Xie YY, Jun-Gan, Yang Z, et al
    Dynamic changes of soluble HLA-G and cytokine plasma levels in cervical cancer patients: potential role in cancer progression and immunotherapy.
    J Cancer Res Clin Oncol. 2022 Sep 2. pii: 10.1007/s00432-022-04331.
    PubMed         Abstract available


    J Exp Clin Cancer Res

  44. LIANG L, Zhu Y, Li J, Zeng J, et al
    ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription.
    J Exp Clin Cancer Res. 2022;41:261.
    PubMed         Abstract available


    J Gynecol Obstet Hum Reprod

  45. LEFEBVRE A, Raimond E, Chauvet P, Touboul C, et al
    Trachelectomy: How is it actually done? A review from FRANCOGYN group Titre: Trachelectomie: comment faire en pratique ? Revue de la litterature par le groupe FRANCOGYN.
    J Gynecol Obstet Hum Reprod. 2022;51:102407.
    PubMed         Abstract available


    J Gynecol Oncol

  46. TAKAHASHI T, Matsuoka H, Sakurai R, Akatsuka J, et al
    Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosis.
    J Gynecol Oncol. 2022;33:e57.
    PubMed         Abstract available


    J Obstet Gynaecol Res

  47. SI C, Yang L, Cai X
    LncRNA LINC00649 aggravates the progression of cervical cancer through sponging miR-216a-3p.
    J Obstet Gynaecol Res. 2022 Aug 29. doi: 10.1111/jog.15405.
    PubMed         Abstract available

  48. JIANG Y, Huang X, Liang P, Qian H, et al
    Low erythrocyte folate levels and increased risk of invasive cervical cancer in Chinese women.
    J Obstet Gynaecol Res. 2022 Aug 30. doi: 10.1111/jog.15411.
    PubMed         Abstract available


    J Oncol

  49. ZHANG Y, Tang X, Ma S, Shen M, et al
    Association between Three Therapeutic Strategies and Clinical Outcomes of 2009 FIGO Stage IB2/IIA2 Cervical Cancer.
    J Oncol. 2022;2022:9497798.
    PubMed         Abstract available


    J Transl Med

  50. WU J, Wu Y, Guo Q, Chen S, et al
    SPOP promotes cervical cancer progression by inducing the movement of PD-1 away from PD-L1 in spatial localization.
    J Transl Med. 2022;20:384.
    PubMed         Abstract available


    Oncol Lett

  51. WANG Y, Xia W, Shen F, Zhou J, et al
    tRNA-derived fragment tRF-Glu49 inhibits cell proliferation, migration and invasion in cervical cancer by targeting FGL1.
    Oncol Lett. 2022;24:334.
    PubMed         Abstract available


    Pan Afr Med J

  52. MAPOKO BSE, Mayeh AMM, Mapenya RRM, Mbassi EDB, et al
    [Epidemiological and clinical features of cervical cancer in Cameroon: experience in the Douala General Hospital].
    Pan Afr Med J. 2022;42:109.
    PubMed         Abstract available


    PLoS One

  53. LUBEYA MK, Mwanahamuntu M, Chibwesha C, Mukosha M, et al
    Implementation strategies to increase human papillomavirus vaccination uptake for adolescent girls in sub-Saharan Africa: A scoping review protocol.
    PLoS One. 2022;17:e0267617.
    PubMed         Abstract available

  54. HOMBAIAH C, Madhu B, Gopi A, Narayana Murthy MR, et al
    Effects of mobile Health (mHealth) application on cervical cancer prevention knowledge and screening among women social support groups with low-socioeconomic status in Mysuru city, Southern India.
    PLoS One. 2022;17:e0273070.
    PubMed         Abstract available

  55. YOSHIKAWA N, Yoshihara M, Tamauchi S, Ikeda Y, et al
    Hypoalbuminemia for the prediction of survival in patients with stage IVB cervical cancer.
    PLoS One. 2022;17:e0273876.
    PubMed         Abstract available


    Proteomics Clin Appl

  56. ALJAWAD MF, Faisal AHMA, Alqanbar MF, Wilmarth PA, et al
    Tandem mass tag-based quantitative proteomic analysis of cervical cancer.
    Proteomics Clin Appl. 2022 Aug 27:e2100105. doi: 10.1002/prca.202100105.
    PubMed         Abstract available


    Radiat Oncol

  57. TAO C, Liu B, Li C, Zhu J, et al
    A novel knowledge-based prediction model for estimating an initial equivalent uniform dose in semi-auto-planning for cervical cancer.
    Radiat Oncol. 2022;17:151.
    PubMed         Abstract available


    Rejuvenation Res

  58. TIAN J, Li Z, Jiang Y, Gu W, et al
    Downregulation of SOX21-AS1 alleviated cisplatin resistance in cervical cancer through Epithelial-messenchymal transition (EMT) inhibition.
    Rejuvenation Res. 2022 Aug 30. doi: 10.1089/rej.2022.0009.
    PubMed         Abstract available


    Reprod Health

  59. HOSSEINI Z, Mohseni S, Momeni R, Aghamolaei T, et al
    Increasing cervical cancer screening in Iran: effectiveness of a theory-based educational intervention.
    Reprod Health. 2022;19:186.
    PubMed         Abstract available


    Sci Rep

  60. AYANTO SY, Belachew T, Wordofa MA
    Determinants of cervical cancer screening utilization among women in Southern Ethiopia.
    Sci Rep. 2022;12:14830.
    PubMed         Abstract available


    Sex Health

  61. WOODWARD S, Luu J, Mesure J, Wynne K, et al
    A collaborative model aligning adult sexual health and endocrine gender health services.
    Sex Health. 2022;19:386-390.
    PubMed         Abstract available


    Virol J

  62. WANG L, He L, Chen J, Wei S, et al
    HPV and vaginal microecological disorders in infertile women: a cross-sectional study in the Chinese population.
    Virol J. 2022;19:137.
    PubMed         Abstract available


    Zhonghua Fu Chan Ke Za Zhi

  63. XIAO JJ, Chen ZR, Wang Q, Sui L, et al
    [Stratified research on related risk factors of CIN(+) in CIN patients diagnosed by endocervical curettage under colposcopy].
    Zhonghua Fu Chan Ke Za Zhi. 2022;57:608-617.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: